Director, Pharmacokinetics, Modeling and Simulation Astellas Pharma, Illinois
Join Amit Desai and several authors in Poster Forum #7 in the Solution Center for a great scientific conversation about posters on the topics, “Pediatrics, Model Informed Decision Making, and Biowaivers”, that he is especially excited about.
M1530-10-69 A Simulation-Based Decision Guide to Evaluate Missing Data in Bioequivalence Studies, Minh Ngoc Le, Biopharma Services, Inc.
T1230-10-65 A Survey of Prevalence of Pediatric Dosing for Biologics, Mohamed Ismail Nounou, Ph.D., US Food and Drug Administration
T1530-10-67 Ex Vivo Platforms (Perfused Liver/Kidney and Intestinal Tissue) including PBPK Modeling Enabling Human PK Predictions and Metabolite Synthesis, Steven Erpelinck, M.B.A., TNO
M1130-10-66 Pharmacokinetics of Mitragynine, a Kratom Alkaloid, in Pregnant Rats: Implications for Maternal and Fetal Health, Michelle Kuntz, BS, University of Florida
T1430-11-75 Suitability of Isavuconazonium Sulfate as a Biopharmaceutics Classification System (BCS)-Based Biowaiver Candidate, David Plano, Fraunhofer Institute for Translational Medicine and Pharmacology
M1230-05-32 Using a Semi-Mechanistic Model to Predict Efficacious Dosing Regimens and Optimal Drug Design Properties for a LNP-Delivered mRNA UGT1A1 Replacement Therapy in Crigler-Najjar Syndrome Type 1 Patients, Jamie Nosbisch, Ph.D., Applied BioMath, LLC